Literature DB >> 11811941

Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid.

Qian Yang1, Manuchehr Abedi-Valugerdi, Yi Xie, Xiao-Yan Zhao, Göran Möller, B Dean Nelson, Joseph W DePierre.   

Abstract

In a previous investigation, we demonstrated that severe thymus and spleen atrophy occurs in mice upon dietary exposure to several potent peroxisome proliferators (PPs). In the present investigation, the effects of the potent PP perfluorooctanoic acid (PFOA) on the adaptive immunity of mice was evaluated both in vivo and ex vivo. The in vivo immune response examined involved immunization of mice with horse red blood cells (HRBCs), displaying T-cell-dependent antigens after pre-treatment with a PFOA-containing diet for 10 days. Subsequent quantitation of the primary humoral response was performed employing both the plaque-forming cell (PFC) assay and determination of the antibody titer by ELISA. The results clearly demonstrate that oral administration of PFOA prevents both the increases in plaque formations by anti-IgM and -IgG and in serum levels of IgM and IgG normally evoked by such immunization. Ex vivo spleen cells proliferation (assayed as incorporation of 3H-thymidine) in response to both T- and B-cell activators was attenuated by dietary treatment with PFOA, although the analogous in vitro treatment of mouse spleen cells with this same compound had no such effects. Thus, the relatively metabolically inert PP PFOA may exert adaptive immunosuppression in mice by an indirect mechanism. The possible relevance of this immunosuppression to the alterations in plasma lipids caused by PPs is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11811941     DOI: 10.1016/s1567-5769(01)00164-3

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  25 in total

1.  Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice.

Authors:  Patricia A Fair; Erin Driscoll; Meagan A M Mollenhauer; Sarah G Bradshaw; Se Hun Yun; Kurunthachalam Kannan; Gregory D Bossart; Deborah E Keil; Margie M Peden-Adams
Journal:  J Immunotoxicol       Date:  2011-01-24       Impact factor: 3.000

2.  Acute Immunotoxic Effects of Perfluorononanoic Acid (PFNA) in C57BL/6 Mice.

Authors:  Cheryl E Rockwell; Alexandra E Turley; Xingguo Cheng; Patrick E Fields; Curtis D Klaassen
Journal:  Clin Exp Pharmacol       Date:  2013

Review 3.  Perfluorinated compounds: emerging POPs with potential immunotoxicity.

Authors:  Emanuela Corsini; Robert W Luebke; Dori R Germolec; Jamie C DeWitt
Journal:  Toxicol Lett       Date:  2014-02-03       Impact factor: 4.372

4.  Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry.

Authors:  Madisa B Macon; LaTonya R Villanueva; Katoria Tatum-Gibbs; Robert D Zehr; Mark J Strynar; Jason P Stanko; Sally S White; Laurence Helfant; Suzanne E Fenton
Journal:  Toxicol Sci       Date:  2011-04-11       Impact factor: 4.849

5.  Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.

Authors:  Claire Looker; Michael I Luster; Antonia M Calafat; Victor J Johnson; Gary R Burleson; Florence G Burleson; Tony Fletcher
Journal:  Toxicol Sci       Date:  2013-11-27       Impact factor: 4.849

Review 6.  Developmental Exposures to Perfluoroalkyl Substances (PFASs): An Update of Associated Health Outcomes.

Authors:  Zeyan Liew; Houman Goudarzi; Youssef Oulhote
Journal:  Curr Environ Health Rep       Date:  2018-03

7.  Gene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent Effects.

Authors:  Mitchell B Rosen; Judith R Schmid; J Christopher Corton; Robert D Zehr; Kaberi P Das; Barbara D Abbott; Christopher Lau
Journal:  PPAR Res       Date:  2010-09-27       Impact factor: 4.964

8.  In vitro evaluation of the effects of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) on IL-2 production in human T-cells.

Authors:  Kristin Midgett; Margie M Peden-Adams; Gary S Gilkeson; Diane L Kamen
Journal:  J Appl Toxicol       Date:  2014-07-23       Impact factor: 3.446

9.  Congenital anomalies, labor/delivery complications, maternal risk factors and their relationship with perfluorooctanoic acid (PFOA)-contaminated public drinking water.

Authors:  Lynda A Nolan; John M Nolan; Frances S Shofer; Nancy V Rodway; Edward A Emmett
Journal:  Reprod Toxicol       Date:  2009-11-06       Impact factor: 3.143

10.  Waste type, incineration, and aeration are associated with per- and polyfluoroalkyl levels in landfill leachates.

Authors:  Helena M Solo-Gabriele; Athena S Jones; Andrew B Lindstrom; Johnsie R Lang
Journal:  Waste Manag       Date:  2020-04-15       Impact factor: 7.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.